BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Löscher W, Brandt C. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev 2010;62:668-700. [PMID: 21079040 DOI: 10.1124/pr.110.003046] [Cited by in Crossref: 259] [Cited by in F6Publishing: 251] [Article Influence: 23.5] [Reference Citation Analysis]
Number Citing Articles
1 Mirza N, Sills GJ, Pirmohamed M, Marson AG. Identifying new antiepileptic drugs through genomics-based drug repurposing. Hum Mol Genet 2017;26:527-37. [PMID: 28053048 DOI: 10.1093/hmg/ddw410] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
2 Ali AE, Mahdy HM, Elsherbiny DM, Azab SS. Rifampicin ameliorates lithium-pilocarpine-induced seizures, consequent hippocampal damage and memory deficit in rats: Impact on oxidative, inflammatory and apoptotic machineries. Biochem Pharmacol 2018;156:431-43. [PMID: 30195730 DOI: 10.1016/j.bcp.2018.09.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
3 Kobow K, Blümcke I. The emerging role of DNA methylation in epileptogenesis. Epilepsia 2012;53 Suppl 9:11-20. [PMID: 23216575 DOI: 10.1111/epi.12031] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 6.7] [Reference Citation Analysis]
4 Russmann V, Seeger N, Zellinger C, Hadamitzky M, Pankratova S, Wendt H, Bock E, Berezin V, Potschka H. The CNTF-derived peptide mimetic Cintrofin attenuates spatial-learning deficits in a rat post-status epilepticus model. Neuroscience Letters 2013;556:170-5. [DOI: 10.1016/j.neulet.2013.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Ohno Y, Kunisawa N, Shimizu S. Emerging Roles of Astrocyte Kir4.1 Channels in the Pathogenesis and Treatment of Brain Diseases. Int J Mol Sci 2021;22:10236. [PMID: 34638578 DOI: 10.3390/ijms221910236] [Reference Citation Analysis]
6 Boison D, Sandau US, Ruskin DN, Kawamura M Jr, Masino SA. Homeostatic control of brain function - new approaches to understand epileptogenesis. Front Cell Neurosci 2013;7:109. [PMID: 23882181 DOI: 10.3389/fncel.2013.00109] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
7 Wang N, Mi X, Gao B, Gu J, Wang W, Zhang Y, Wang X. Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neuroscience 2015;287:144-56. [PMID: 25541249 DOI: 10.1016/j.neuroscience.2014.12.021] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 9.4] [Reference Citation Analysis]
8 Rayatpour A, Farhangi S, Verdaguer E, Olloquequi J, Ureña J, Auladell C, Javan M. The Cross Talk between Underlying Mechanisms of Multiple Sclerosis and Epilepsy May Provide New Insights for More Efficient Therapies. Pharmaceuticals (Basel) 2021;14:1031. [PMID: 34681255 DOI: 10.3390/ph14101031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chwiej J, Gabrys H, Janeczko K, Kutorasinska J, Gzielo-Jurek K, Matusiak K, Appel K, Setkowicz Z. Elemental anomalies in the hippocampal formation after repetitive electrical stimulation: an X-ray fluorescence microscopy study. J Biol Inorg Chem 2014;19:1209-20. [PMID: 25027680 DOI: 10.1007/s00775-014-1177-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
10 Łukawski K, Gryta P, Łuszczki J, Czuczwar SJ. Exploring the latest avenues for antiepileptic drug discovery and development. Expert Opinion on Drug Discovery 2016;11:369-82. [DOI: 10.1517/17460441.2016.1154840] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
11 Zhu L, Chen L, Xu P, Lu D, Dai S, Zhong L, Han Y, Zhang M, Xiao B, Chang L, Wu Q. Genetic and molecular basis of epilepsy-related cognitive dysfunction. Epilepsy Behav 2020;104:106848. [PMID: 32028124 DOI: 10.1016/j.yebeh.2019.106848] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Serrano E, Kanner AM. Recent treatment advances and novel therapeutic approaches in epilepsy. F1000Prime Rep 2015;7:61. [PMID: 26097734 DOI: 10.12703/P7-61] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
13 Kołosowska K, Maciejak P, Szyndler J, Turzyńska D, Sobolewska A, Płaźnik A. The role of IL-1β and glutamate in the effects of lipopolysaccharide on the hippocampal electrical kindling of seizures. J Neuroimmunol 2016;298:146-52. [PMID: 27609288 DOI: 10.1016/j.jneuroim.2016.07.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
14 Van Nieuwenhuyse B, Raedt R, Sprengers M, Dauwe I, Gadeyne S, Carrette E, Delbeke J, Wadman WJ, Boon P, Vonck K. The systemic kainic acid rat model of temporal lobe epilepsy: Long-term EEG monitoring. Brain Res 2015;1627:1-11. [PMID: 26381287 DOI: 10.1016/j.brainres.2015.08.016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
15 Keret A, Bennett-Back O, Rosenthal G, Gilboa T, Shweiki M, Shoshan Y, Benifla M. Posttraumatic epilepsy: long-term follow-up of children with mild traumatic brain injury. J Neurosurg Pediatr 2017;20:64-70. [PMID: 28474982 DOI: 10.3171/2017.2.PEDS16585] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 4.2] [Reference Citation Analysis]
16 Lam PM, Carlsen J, González MI. A calpain inhibitor ameliorates seizure burden in an experimental model of temporal lobe epilepsy. Neurobiol Dis 2017;102:1-10. [PMID: 28237317 DOI: 10.1016/j.nbd.2017.02.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
17 Park SY, Kwon HE, Kang HC, Lee JS, Kim DS, Kim HD. Epilepsy surgery in pediatric intractable epilepsy with destructive encephalopathy. J Epilepsy Res 2013;3:48-53. [PMID: 24649473 DOI: 10.14581/jer.13010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
18 Sucher NJ, Carles MC. A pharmacological basis of herbal medicines for epilepsy. Epilepsy Behav 2015;52:308-18. [PMID: 26074183 DOI: 10.1016/j.yebeh.2015.05.012] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 8.3] [Reference Citation Analysis]
19 Töpfer M, Töllner K, Brandt C, Twele F, Bröer S, Löscher W. Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy. Eur J Neurosci 2014;39:673-87. [PMID: 24251546 DOI: 10.1111/ejn.12424] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
20 Tescarollo FC, Rombo DM, DeLiberto LK, Fedele DE, Alharfoush E, Tomé ÂR, Cunha RA, Sebastião AM, Boison D. Role of Adenosine in Epilepsy and Seizures. J Caffeine Adenosine Res 2020;10:45-60. [PMID: 32566903 DOI: 10.1089/caff.2019.0022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
21 Duncan D, Vespa P, Toga AW. DETECTING FEATURES OF EPILEPTOGENESIS IN EEG AFTER TBI USING UNSUPERVISED DIFFUSION COMPONENT ANALYSIS. Discrete Continuous Dyn Syst Ser B 2018;23:161-72. [PMID: 30369835 DOI: 10.3934/dcdsb.2018010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 D'Ambrosio R, Eastman CL, Fattore C, Perucca E. Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation. Expert Rev Neurother 2013;13:615-25. [PMID: 23738999 DOI: 10.1586/ern.13.54] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
23 Tsverava L, Lordkipanidze T, Lepsveridze E, Nozadze M, Kikvidze M, Solomonia R. Myoinositol Attenuates the Cell Loss and Biochemical Changes Induced by Kainic Acid Status Epilepticus. Biomed Res Int 2016;2016:2794096. [PMID: 27642592 DOI: 10.1155/2016/2794096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
24 Reddy DS, Bhimani A, Kuruba R, Park MJ, Sohrabji F. Prospects of modeling poststroke epileptogenesis. J Neurosci Res 2017;95:1000-16. [PMID: 27452210 DOI: 10.1002/jnr.23836] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
25 Jin Y, Cai S, Jiang Y, Zhong K, Wen C, Ruan Y, Chew LA, Khanna R, Xu Z, Yu J. Tetramethylpyrazine Reduces Epileptogenesis Progression in Electrical Kindling Models by Modulating Hippocampal Excitatory Neurotransmission. ACS Chem Neurosci 2019;10:4854-63. [PMID: 31756074 DOI: 10.1021/acschemneuro.9b00575] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
26 Hasan MF, Berdichevsky Y. Neuron and astrocyte aggregation and sorting in three-dimensional neuronal constructs. Commun Biol 2021;4:587. [PMID: 34002005 DOI: 10.1038/s42003-021-02104-2] [Reference Citation Analysis]
27 Delfino-Pereira P, Bertti-Dutra P, Del Vecchio F, de Oliveira JAC, Medeiros DC, Cestari DM, Santos VR, Moraes MFD, Rosa JLG, Mendes EMAM, Garcia-Cairasco N. Behavioral and EEGraphic Characterization of the Anticonvulsant Effects of the Predator Odor (TMT) in the Amygdala Rapid Kindling, a Model of Temporal Lobe Epilepsy. Front Neurol 2020;11:586724. [PMID: 33250852 DOI: 10.3389/fneur.2020.586724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Oliveira CV, Zorzi VN, Fighera MR, Royes LFF, Furian AF, Oliveira MS. Subtle improvement of seizure susceptibility by atorvastatin treatment during epileptogenesis. Pharmacol Rep 2018;70:364-71. [PMID: 29477945 DOI: 10.1016/j.pharep.2017.08.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
29 Vega-García A, Orozco-Suárez S, Villa A, Rocha L, Feria-Romero I, Alonso Vanegas MA, Guevara-Guzmán R. Cortical expression of IL1-β, Bcl-2, Caspase-3 and 9, SEMA-3a, NT-3 and P-glycoprotein as biological markers of intrinsic severity in drug-resistant temporal lobe epilepsy. Brain Res 2021;1758:147303. [PMID: 33516813 DOI: 10.1016/j.brainres.2021.147303] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Bankstahl M, Klein S, Römermann K, Löscher W. Knockout of P-glycoprotein does not alter antiepileptic drug efficacy in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice. Neuropharmacology 2016;109:183-95. [PMID: 27288003 DOI: 10.1016/j.neuropharm.2016.06.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
31 Kobow K, Auvin S, Jensen F, Löscher W, Mody I, Potschka H, Prince D, Sierra A, Simonato M, Pitkänen A, Nehlig A, Rho JM. Finding a better drug for epilepsy: antiepileptogenesis targets. Epilepsia 2012;53:1868-76. [PMID: 23061663 DOI: 10.1111/j.1528-1167.2012.03716.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 6.2] [Reference Citation Analysis]
32 Löscher W. The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments. Neuropharmacology 2020;167:107605. [PMID: 30980836 DOI: 10.1016/j.neuropharm.2019.04.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 11.3] [Reference Citation Analysis]
33 Sharp M, Javidan M. Immunomodulation in Adult Epilepsy: The Role of IVIG. Can J Neurol Sci 2012;39:584-91. [DOI: 10.1017/s0317167100015304] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
34 Bragin A, Benassi SK, Engel J Jr. Patterns of the UP-Down state in normal and epileptic mice. Neuroscience 2012;225:76-87. [PMID: 22960310 DOI: 10.1016/j.neuroscience.2012.08.059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
35 Twele F, Töllner K, Brandt C, Löscher W. Significant effects of sex, strain, and anesthesia in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy. Epilepsy Behav 2016;55:47-56. [PMID: 26736063 DOI: 10.1016/j.yebeh.2015.11.027] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
36 Misra UK, Kalita J, Bhoi SK. Practice parameters in management of status epileptics. Ann Indian Acad Neurol 2014;17:S27-31. [PMID: 24791084 DOI: 10.4103/0972-2327.128646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Sandouka S, Shekh-Ahmad T. Induction of the Nrf2 Pathway by Sulforaphane Is Neuroprotective in a Rat Temporal Lobe Epilepsy Model. Antioxidants (Basel) 2021;10:1702. [PMID: 34829573 DOI: 10.3390/antiox10111702] [Reference Citation Analysis]
38 Delfino-pereira P, Berti Dutra P, Cortes de Oliveira JA, Casanova Turatti IC, Fernandes A, Peporine Lopes N, Garcia-cairasco N. Are Predator Smell (TMT)-Induced Behavioral Alterations in Rats Able to Inhibit Seizures? Chemical Senses 2020;45:347-57. [DOI: 10.1093/chemse/bjaa023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Löscher W, Schmidt D. Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma: Ways Out of the Current Dilemma with New AEDs. Epilepsia 2011;52:657-78. [DOI: 10.1111/j.1528-1167.2011.03024.x] [Cited by in Crossref: 345] [Cited by in F6Publishing: 301] [Article Influence: 31.4] [Reference Citation Analysis]
40 Clossen BL, Reddy DS. Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy. Biochim Biophys Acta Mol Basis Dis 2017;1863:1519-38. [PMID: 28179120 DOI: 10.1016/j.bbadis.2017.02.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 8.8] [Reference Citation Analysis]
41 Rattka M, Brandt C, Löscher W. The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats. Epilepsy Res 2013;103:135-52. [PMID: 23196211 DOI: 10.1016/j.eplepsyres.2012.09.015] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 6.2] [Reference Citation Analysis]
42 Kaur N, Singh T, Kumar S, Goel RK. Neurochemical evidence based suggested therapy for safe management of epileptogenesis. Epilepsy & Behavior 2017;72:8-16. [DOI: 10.1016/j.yebeh.2017.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
43 Lévesque M, Macey-dare AD, Wang S, Avoli M. Evolution of interictal spiking during the latent period in a mouse model of mesial temporal lobe epilepsy. Current Research in Neurobiology 2021;2:100008. [DOI: 10.1016/j.crneur.2021.100008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Thom M. Review: Hippocampal sclerosis in epilepsy: a neuropathology review. Neuropathol Appl Neurobiol 2014;40:520-43. [PMID: 24762203 DOI: 10.1111/nan.12150] [Cited by in Crossref: 239] [Cited by in F6Publishing: 201] [Article Influence: 34.1] [Reference Citation Analysis]
45 Vega-García A, Rocha L, Guevara-Guzmán R, Guerra-Araiza C, Feria-Romero I, Gallardo JM, Neri-Gomez T, Suárez-Santiago JE, Orozco-Suarez S. Magnolia officinalis Reduces Inflammation and Damage Induced by Recurrent Status Epilepticus in Immature Rats. Curr Pharm Des 2020;26:1388-401. [PMID: 32196444 DOI: 10.2174/1381612826666200320121813] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
46 Schmidt D, Friedman D, Dichter MA. Anti-epileptogenic clinical trial designs in epilepsy: issues and options. Neurotherapeutics 2014;11:401-11. [PMID: 24420312 DOI: 10.1007/s13311-013-0252-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
47 Löscher W, Puskarjov M, Kaila K. Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments. Neuropharmacology 2013;69:62-74. [PMID: 22705273 DOI: 10.1016/j.neuropharm.2012.05.045] [Cited by in Crossref: 172] [Cited by in F6Publishing: 161] [Article Influence: 17.2] [Reference Citation Analysis]
48 Chen Y, He X, Sun Q, Fang Z, Zhou L. Effect of lamotrigine on seizure development in a rat pentylenetetrazole kindling model. Brain Behav 2017;7:e00727. [PMID: 28729934 DOI: 10.1002/brb3.727] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
49 Löscher W. Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy. Front Pharmacol 2021;12:730257. [PMID: 34776956 DOI: 10.3389/fphar.2021.730257] [Reference Citation Analysis]
50 Sloviter RS. Progress on the issue of excitotoxic injury modification vs. real neuroprotection; implications for post-traumatic epilepsy. Neuropharmacology 2011;61:1048-50. [PMID: 21839755 DOI: 10.1016/j.neuropharm.2011.07.038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
51 Leiter I, Bascuñana P, Bengel FM, Bankstahl JP, Bankstahl M. Attenuation of epileptogenesis by 2-deoxy-d-glucose is accompanied by increased cerebral glucose supply, microglial activation and reduced astrocytosis. Neurobiol Dis 2019;130:104510. [PMID: 31212069 DOI: 10.1016/j.nbd.2019.104510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Sloviter RS, Bumanglag AV. Defining "epileptogenesis" and identifying "antiepileptogenic targets" in animal models of acquired temporal lobe epilepsy is not as simple as it might seem. Neuropharmacology 2013;69:3-15. [PMID: 22342985 DOI: 10.1016/j.neuropharm.2012.01.022] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
53 Zhu X, Liu J, Huang S, Zhu W, Wang Y, Chen O, Xue J. Neuroprotective effects of isoliquiritigenin against cognitive impairment via suppression of synaptic dysfunction, neuronal injury, and neuroinflammation in rats with kainic acid-induced seizures. Int Immunopharmacol. 2019;72:358-366. [PMID: 31030091 DOI: 10.1016/j.intimp.2019.04.028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
54 Zellinger C, Salvamoser JD, Seeger N, Russmann V, Potschka H. Impact of the neural cell adhesion molecule-derived peptide FGL on seizure progression and cellular alterations in the mouse kindling model. ACS Chem Neurosci 2014;5:185-93. [PMID: 24456603 DOI: 10.1021/cn400153g] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
55 Reddy DS, Yoshimura RF, Ramanathan G, Carver C, Johnstone TB, Hogenkamp DJ, Gee KW. Role of β 2/3 -specific GABA-A receptor isoforms in the development of hippocampus kindling epileptogenesis. Epilepsy & Behavior 2018;82:57-63. [DOI: 10.1016/j.yebeh.2018.02.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
56 Li F, Song Y, Dryer A, Cogguillo W, Berdichevsky Y, Zhou C. Nondestructive evaluation of progressive neuronal changes in organotypic rat hippocampal slice cultures using ultrahigh-resolution optical coherence microscopy. Neurophotonics 2014;1:025002. [PMID: 25750928 DOI: 10.1117/1.NPh.1.2.025002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
57 Diviney M, Reynolds JP, Henshall DC. Comparison of short-term effects of midazolam and lorazepam in the intra-amygdala kainic acid model of status epilepticus in mice. Epilepsy Behav 2015;51:191-8. [PMID: 26291773 DOI: 10.1016/j.yebeh.2015.07.038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
58 Kim YS, Choi MY, Lee DH, Jeon BT, Roh GS, Kim HJ, Kang SS, Cho GJ, Choi WS. Decreased interaction between FoxO3a and Akt correlates with seizure-induced neuronal death. Epilepsy Res 2014;108:367-78. [PMID: 24518891 DOI: 10.1016/j.eplepsyres.2014.01.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
59 Chen M, Arumugam TV, Leanage G, Tieng QM, Yadav A, Ullmann JF, She DT, Truong V, Ruitenberg MJ, Reutens DC. Disease-modifying effect of intravenous immunoglobulin in an experimental model of epilepsy. Sci Rep 2017;7:40528. [PMID: 28074934 DOI: 10.1038/srep40528] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
60 Leclercq K, Liefferinge JV, Albertini G, Neveux M, Dardenne S, Mairet‐coello G, Vandenplas C, Deprez T, Chong S, Foerch P, Bentea E, Sato H, Maher P, Massie A, Smolders I, Kaminski RM. Anticonvulsant and antiepileptogenic effects of system xc− inactivation in chronic epilepsy models. Epilepsia 2019;60:1412-23. [DOI: 10.1111/epi.16055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
61 Yang L, Cai X, Zhou J, Chen S, Chen Y, Chen Z, Wang Q, Fang Z, Zhou L. STE20/SPS1-related proline/alanine-rich kinase is involved in plasticity of GABA signaling function in a mouse model of acquired epilepsy. PLoS One 2013;8:e74614. [PMID: 24058604 DOI: 10.1371/journal.pone.0074614] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
62 Ghadiri T, Vakilzadeh G, Hajali V, Khodagholi F. Progesterone modulates post-traumatic epileptogenesis through regulation of BDNF-TrkB signaling and cell survival-related pathways in the rat hippocampus. Neurosci Lett 2019;709:134384. [PMID: 31325580 DOI: 10.1016/j.neulet.2019.134384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
63 Upadhya D, Hattiangady B, Castro OW, Shuai B, Kodali M, Attaluri S, Bates A, Dong Y, Zhang SC, Prockop DJ, Shetty AK. Human induced pluripotent stem cell-derived MGE cell grafting after status epilepticus attenuates chronic epilepsy and comorbidities via synaptic integration. Proc Natl Acad Sci U S A 2019;116:287-96. [PMID: 30559206 DOI: 10.1073/pnas.1814185115] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
64 González MI, Cruz Del Angel Y, Brooks-Kayal A. Down-regulation of gephyrin and GABAA receptor subunits during epileptogenesis in the CA1 region of hippocampus. Epilepsia 2013;54:616-24. [PMID: 23294024 DOI: 10.1111/epi.12063] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
65 Canto AM, Matos AHB, Godoi AB, Vieira AS, Aoyama BB, Rocha CS, Henning B, Carvalho BS, Pascoal VDB, Veiga DFT, Gilioli R, Cendes F, Lopes-Cendes I. Multi-omics analysis suggests enhanced epileptogenesis in the Cornu Ammonis 3 of the pilocarpine model of mesial temporal lobe epilepsy. Hippocampus 2021;31:122-39. [PMID: 33037862 DOI: 10.1002/hipo.23268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
66 Pitkänen A, Nehlig A, Brooks-Kayal AR, Dudek FE, Friedman D, Galanopoulou AS, Jensen FE, Kaminski RM, Kapur J, Klitgaard H, Löscher W, Mody I, Schmidt D. Issues related to development of antiepileptogenic therapies. Epilepsia 2013;54 Suppl 4:35-43. [PMID: 23909852 DOI: 10.1111/epi.12297] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 7.9] [Reference Citation Analysis]
67 Welzel L, Bergin DH, Schidlitzki A, Twele F, Johne M, Klein P, Löscher W. Systematic evaluation of rationally chosen multitargeted drug combinations: a combination of low doses of levetiracetam, atorvastatin and ceftriaxone exerts antiepileptogenic effects in a mouse model of acquired epilepsy. Neurobiol Dis 2021;149:105227. [PMID: 33347976 DOI: 10.1016/j.nbd.2020.105227] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Seeger N, Zellinger C, Rode A, Roloff F, Bicker G, Russmann V, Fischborn S, Wendt H, Potschka H. The erythropoietin-derived peptide mimetic pHBSP affects cellular and cognitive consequences in a rat post-status epilepticus model. Epilepsia 2011;52:2333-43. [PMID: 22050420 DOI: 10.1111/j.1528-1167.2011.03302.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
69 Mishra NK, Engel J Jr, Liebeskind DS, Sharma VK, Hirsch LJ, Kasner SE, French JA, Devinsky O, Friedman A, Dawson J, Quinn TJ, Selim M, de Havenon A, Yasuda CL, Cendes F, Benninger F, Zaveri HP, Burneo JG, Srivastava P, Bhushan Singh M, Bhatia R, Vishnu VY, Bentes C, Ferro J, Weiss S, Sivaraju A, Kim JA, Galovic M, Gilmore EJ, Pitkänen A, Davis K, Sansing LH, Sheth KN, Paz JT, Singh A, Sheth S, Worrall BB, Grotta JC, Casillas-Espinos PM, Chen Z, Nicolo JP, Yan B, Kwan P; for International Post Stroke Epilepsy Research Consortium (IPSERC). International Post Stroke Epilepsy Research Consortium (IPSERC): A consortium to accelerate discoveries in preventing epileptogenesis after stroke. Epilepsy Behav 2021;127:108502. [PMID: 34968775 DOI: 10.1016/j.yebeh.2021.108502] [Reference Citation Analysis]
70 Lusardi TA, Akula KK, Coffman SQ, Ruskin DN, Masino SA, Boison D. Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats. Neuropharmacology. 2015;99:500-509. [PMID: 26256422 DOI: 10.1016/j.neuropharm.2015.08.007] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 10.0] [Reference Citation Analysis]
71 Bar-Klein G, Klee R, Brandt C, Bankstahl M, Bascuñana P, Töllner K, Dalipaj H, Bankstahl JP, Friedman A, Löscher W. Isoflurane prevents acquired epilepsy in rat models of temporal lobe epilepsy. Ann Neurol 2016;80:896-908. [PMID: 27761920 DOI: 10.1002/ana.24804] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
72 Klein P, Herr D, Pearl PL, Natale J, Levine Z, Nogay C, Sandoval F, Trzcinsky S, Atabaki SM, Tsuchida T, van den Anker J, Soldin SJ, He J, McCarter R. Results of phase II pharmacokinetic study of levetiracetam for prevention of post-traumatic epilepsy. Epilepsy Behav 2012;24:457-61. [PMID: 22771222 DOI: 10.1016/j.yebeh.2012.05.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
73 Zellinger C, Seeger N, Hadamitzky M, Fischborn S, Russmann V, Wendt H, Pankratova S, Bock E, Berezin V, Potschka H. Impact of the erythropoietin-derived peptide mimetic Epotris on the histopathological consequences of status epilepticus. Epilepsy Research 2011;96:241-9. [DOI: 10.1016/j.eplepsyres.2011.06.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
74 Brackhan M, Bascuñana P, Postema JM, Ross TL, Bengel FM, Bankstahl M, Bankstahl JP. Serial Quantitative TSPO-Targeted PET Reveals Peak Microglial Activation up to 2 Weeks After an Epileptogenic Brain Insult. J Nucl Med 2016;57:1302-8. [PMID: 27056616 DOI: 10.2967/jnumed.116.172494] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
75 Kunda S, Lafrance-corey RG, Khadjevand F, Worrell GA, Howe CL. Systemic evidence of acute seizure-associated elevation in serum neuronal injury biomarker in patients with temporal lobe epilepsy. Acta Epileptologica 2019;1. [DOI: 10.1186/s42494-019-0001-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
76 Łukawski K, Czuczwar SJ. Developing precision treatments for epilepsy using patient and animal models. Expert Rev Neurother 2020;:1-10. [PMID: 33339471 DOI: 10.1080/14737175.2021.1866989] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Rogawski MA, Tofighy A, White HS, Matagne A, Wolff C. Current understanding of the mechanism of action of the antiepileptic drug lacosamide. Epilepsy Research 2015;110:189-205. [DOI: 10.1016/j.eplepsyres.2014.11.021] [Cited by in Crossref: 97] [Cited by in F6Publishing: 82] [Article Influence: 13.9] [Reference Citation Analysis]
78 Rismanchi N, Gold JJ, Sattar S, Glaser C, Sheriff H, Proudfoot J, Mower A, Nespeca M, Crawford JR, Wang SG. Neurological Outcomes After Presumed Childhood Encephalitis. Pediatric Neurology 2015;53:200-6. [DOI: 10.1016/j.pediatrneurol.2015.05.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
79 Löscher W, Ferland RJ, Ferraro TN. The relevance of inter- and intrastrain differences in mice and rats and their implications for models of seizures and epilepsy. Epilepsy Behav 2017;73:214-35. [PMID: 28651171 DOI: 10.1016/j.yebeh.2017.05.040] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
80 Radzik I, Miziak B, Dudka J, Chrościńska-Krawczyk M, Czuczwar SJ. Prospects of epileptogenesis prevention. Pharmacol Rep 2015;67:663-8. [PMID: 25933984 DOI: 10.1016/j.pharep.2015.01.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
81 Löscher W, Klein P. New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal? Pharmacol Ther 2021;:107934. [PMID: 34216705 DOI: 10.1016/j.pharmthera.2021.107934] [Reference Citation Analysis]
82 Suleymanova E, Gulyaev M, Chepurnova N. Ginseng extract attenuates early MRI changes after status epilepticus and decreases subsequent reduction of hippocampal volume in the rat brain. Epilepsy Research 2014;108:223-31. [DOI: 10.1016/j.eplepsyres.2013.11.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
83 Steinbrenner M, Kowski AB, Schmitt FC, Holtkamp M. Hypothermia did not prevent epilepsy following experimental status epilepticus. Brain Res 2014;1572:50-8. [PMID: 24854118 DOI: 10.1016/j.brainres.2014.05.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
84 Dzhala V, Staley KJ. Acute and chronic efficacy of bumetanide in an in vitro model of posttraumatic epileptogenesis. CNS Neurosci Ther 2015;21:173-80. [PMID: 25495911 DOI: 10.1111/cns.12369] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
85 Aksoz E, Sara Y, Onur R. T-type Ca2+ channel activity increases in rat hippocampal CA1 region during kindling epileptogenesis. Synapse 2020;74:e22155. [PMID: 32215948 DOI: 10.1002/syn.22155] [Reference Citation Analysis]
86 Löscher W, Gillard M, Sands ZA, Kaminski RM, Klitgaard H. Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond. CNS Drugs 2016;30:1055-77. [PMID: 27752944 DOI: 10.1007/s40263-016-0384-x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 17.8] [Reference Citation Analysis]
87 Margineanu DG. Systems biology impact on antiepileptic drug discovery. Epilepsy Res 2012;98:104-15. [PMID: 22055355 DOI: 10.1016/j.eplepsyres.2011.10.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
88 Meller S, Käufer C, Gailus B, Brandt C, Löscher W. Scopolamine prevents aberrant mossy fiber sprouting and facilitates remission of epilepsy after brain injury. Neurobiol Dis 2021;158:105446. [PMID: 34280524 DOI: 10.1016/j.nbd.2021.105446] [Reference Citation Analysis]
89 Tse K, Beamer E, Simpson D, Beynon RJ, Sills GJ, Thippeswamy T. The Impacts of Surgery and Intracerebral Electrodes in C57BL/6J Mouse Kainate Model of Epileptogenesis: Seizure Threshold, Proteomics, and Cytokine Profiles. Front Neurol 2021;12:625017. [PMID: 34322075 DOI: 10.3389/fneur.2021.625017] [Reference Citation Analysis]
90 Brandt C, Töllner K, Klee R, Bröer S, Löscher W. Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: Window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers. Neurobiol Dis 2015;75:78-90. [PMID: 25549873 DOI: 10.1016/j.nbd.2014.12.015] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 6.5] [Reference Citation Analysis]
91 Wang J, Chen Y, Wang Q, van Luijtelaar G, Sun M. The effects of lamotrigine and ethosuximide on seizure frequency, neuronal loss, and astrogliosis in a model of temporal-lobe epilepsy. Brain Research 2019;1712:1-6. [DOI: 10.1016/j.brainres.2019.01.031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
92 Copmans D, Siekierska A, de Witte PA. Zebrafish Models of Epilepsy and Epileptic Seizures. Models of Seizures and Epilepsy. Elsevier; 2017. pp. 369-84. [DOI: 10.1016/b978-0-12-804066-9.00026-2] [Cited by in Crossref: 8] [Article Influence: 1.6] [Reference Citation Analysis]
93 McElroy PB, Liang LP, Day BJ, Patel M. Scavenging reactive oxygen species inhibits status epilepticus-induced neuroinflammation. Exp Neurol 2017;298:13-22. [PMID: 28822838 DOI: 10.1016/j.expneurol.2017.08.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
94 Becker AJ. Review: Animal models of acquired epilepsy: insights into mechanisms of human epileptogenesis. Neuropathol Appl Neurobiol 2018;44:112-29. [DOI: 10.1111/nan.12451] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 12.8] [Reference Citation Analysis]
95 Altenmüller DM, Hebel JM, Rassner MP, Volz S, Freiman TM, Feuerstein TJ, Zentner J. Locally applied valproate enhances survival in rats after neocortical treatment with tetanus toxin and cobalt chloride. Biomed Res Int 2013;2013:497485. [PMID: 24151604 DOI: 10.1155/2013/497485] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
96 Lidster K, Jefferys JG, Blümcke I, Crunelli V, Flecknell P, Frenguelli BG, Gray WP, Kaminski R, Pitkänen A, Ragan I, Shah M, Simonato M, Trevelyan A, Volk H, Walker M, Yates N, Prescott MJ. Opportunities for improving animal welfare in rodent models of epilepsy and seizures. J Neurosci Methods 2016;260:2-25. [PMID: 26376175 DOI: 10.1016/j.jneumeth.2015.09.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
97 Sharma S, Puttachary S, Thippeswamy T. Glial source of nitric oxide in epileptogenesis: A target for disease modification in epilepsy. J Neurosci Res 2019;97:1363-77. [PMID: 29230865 DOI: 10.1002/jnr.24205] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
98 Reschke CR, Henshall DC. microRNA and Epilepsy. Adv Exp Med Biol 2015;888:41-70. [PMID: 26663178 DOI: 10.1007/978-3-319-22671-2_4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
99 Trinka E, Brigo F. Antiepileptogenesis in humans: disappointing clinical evidence and ways to move forward. Current Opinion in Neurology 2014;27:227-35. [DOI: 10.1097/wco.0000000000000067] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 4.9] [Reference Citation Analysis]
100 Caccamo D, Pisani LR, Mazzocchetti P, Ientile R, Calabresi P, Pisani F, Costa C. Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs. Neurochem Res 2016;41:340-52. [PMID: 26721507 DOI: 10.1007/s11064-015-1809-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
101 Margineanu DG. Systems biology, complexity, and the impact on antiepileptic drug discovery. Epilepsy & Behavior 2014;38:131-42. [DOI: 10.1016/j.yebeh.2013.08.029] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
102 Tanaka T, Litofsky NS. Anti-epileptic drugs in pediatric traumatic brain injury. Expert Review of Neurotherapeutics 2016;16:1229-34. [DOI: 10.1080/14737175.2016.1200974] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
103 Alexopoulos AV. Pharmacoresistant epilepsy: Definition and explanation. Epileptology 2013;1:38-42. [DOI: 10.1016/j.epilep.2013.01.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
104 Russo E, Scicchitano F, Citraro R, Aiello R, Camastra C, Mainardi P, Chimirri S, Perucca E, Donato G, De Sarro G. Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. Neuroscience 2012;226:282-8. [PMID: 23000629 DOI: 10.1016/j.neuroscience.2012.09.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
105 Jimenez-Mateos EM, Engel T, Merino-Serrais P, Fernaud-Espinosa I, Rodriguez-Alvarez N, Reynolds J, Reschke CR, Conroy RM, McKiernan RC, deFelipe J, Henshall DC. Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epilepticus. Brain Struct Funct 2015;220:2387-99. [PMID: 24874920 DOI: 10.1007/s00429-014-0798-5] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 8.3] [Reference Citation Analysis]
106 François J, Germe K, Ferrandon A, Koning E, Nehlig A. Carisbamate has powerful disease-modifying effects in the lithium-pilocarpine model of temporal lobe epilepsy. Neuropharmacology 2011;61:313-28. [PMID: 21539848 DOI: 10.1016/j.neuropharm.2011.04.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
107 Szaflarski JP, Nazzal Y, Dreer LE. Post-traumatic epilepsy: current and emerging treatment options. Neuropsychiatr Dis Treat 2014;10:1469-77. [PMID: 25143737 DOI: 10.2147/NDT.S50421] [Cited by in Crossref: 38] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
108 Totola LT, Malheiros-lima MR, Delfino-pereira P, Del Vecchio F, Souza FC, Takakura AC, Garcia-cairasco N, Moreira TS. Amygdala rapid kindling impairs breathing in response to chemoreflex activation. Brain Research 2019;1718:159-68. [DOI: 10.1016/j.brainres.2019.05.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
109 Noe FM, Polascheck N, Frigerio F, Bankstahl M, Ravizza T, Marchini S, Beltrame L, Banderó CR, Löscher W, Vezzani A. Pharmacological blockade of IL-1β/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy. Neurobiol Dis 2013;59:183-93. [PMID: 23938763 DOI: 10.1016/j.nbd.2013.07.015] [Cited by in Crossref: 107] [Cited by in F6Publishing: 104] [Article Influence: 11.9] [Reference Citation Analysis]
110 Klein P, Friedman A, Hameed MQ, Kaminski RM, Bar-Klein G, Klitgaard H, Koepp M, Jozwiak S, Prince DA, Rotenberg A, Twyman R, Vezzani A, Wong M, Löscher W. Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy? Epilepsia 2020;61:359-86. [PMID: 32196665 DOI: 10.1111/epi.16450] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
111 Rattka M, Brandt C, Löscher W. Do proconvulsants modify or halt epileptogenesis? Pentylenetetrazole is ineffective in two rat models of temporal lobe epilepsy: Pentylenetetrazole and epileptogenesis. European Journal of Neuroscience 2012;36:2505-20. [DOI: 10.1111/j.1460-9568.2012.08143.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
112 Goldberg EM, Coulter DA. Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat Rev Neurosci 2013;14:337-49. [PMID: 23595016 DOI: 10.1038/nrn3482] [Cited by in Crossref: 252] [Cited by in F6Publishing: 235] [Article Influence: 28.0] [Reference Citation Analysis]
113 Rismanchi N, Gold JJ, Sattar S, Glaser CA, Sheriff H, Proudfoot J, Mower A, Crawford JR, Nespeca M, Wang SG. Epilepsy After Resolution of Presumed Childhood Encephalitis. Pediatric Neurology 2015;53:65-72. [DOI: 10.1016/j.pediatrneurol.2015.03.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
114 von Rüden E, Jafari M, Bogdanovic R, Wotjak C, Potschka H. Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm. Neurobiology of Disease 2015;73:334-47. [DOI: 10.1016/j.nbd.2014.08.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
115 González MI. The possible role of GABAA receptors and gephyrin in epileptogenesis. Front Cell Neurosci 2013;7:113. [PMID: 23885234 DOI: 10.3389/fncel.2013.00113] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
116 Löscher W. Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies. Epilepsy Res 2016;126:157-84. [PMID: 27505294 DOI: 10.1016/j.eplepsyres.2016.05.016] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 13.7] [Reference Citation Analysis]
117 Colciaghi F, Finardi A, Nobili P, Locatelli D, Spigolon G, Battaglia GS. Progressive brain damage, synaptic reorganization and NMDA activation in a model of epileptogenic cortical dysplasia. PLoS One 2014;9:e89898. [PMID: 24587109 DOI: 10.1371/journal.pone.0089898] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
118 de la Tremblaye PB, O'Neil DA, LaPorte MJ, Cheng JP, Beitchman JA, Thomas TC, Bondi CO, Kline AE. Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation. Neurosci Biobehav Rev 2018;85:160-75. [PMID: 28576511 DOI: 10.1016/j.neubiorev.2017.05.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
119 Lee CH, Koo HW, Han SR, Choi CY, Sohn MJ, Lee CH. Phenytoin versus levetiracetam as prophylaxis for postcraniotomy seizure in patients with no history of seizures: systematic review and meta-analysis. J Neurosurg 2019;130:1-8. [PMID: 30004278 DOI: 10.3171/2018.4.JNS1891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
120 Stafstrom CE. Issues in Clinical Epileptology: A View from the Bench. A Festschrift in Honor of Philip A. Schwartzkroin, PhD. Epilepsy Curr 2013;13:291-6. [PMID: 24348132 DOI: 10.5698/1535-7597-13.6.291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
121 Suleymanova E, Gulyaev M, Abbasova K. Structural alterations in the rat brain and behavioral impairment after status epilepticus: An MRI study. Neuroscience 2016;315:79-90. [DOI: 10.1016/j.neuroscience.2015.11.061] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
122 Biagini G, Rustichelli C, Curia G, Vinet J, Lucchi C, Pugnaghi M, Meletti S. Neurosteroids and Epileptogenesis. J Neuroendocrinol 2013;25:980-90. [DOI: 10.1111/jne.12063] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
123 Engel J Jr. Biomarkers in epilepsy: introduction. Biomark Med 2011;5:537-44. [PMID: 22003902 DOI: 10.2217/bmm.11.62] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
124 van der Hel WS, Hessel EV, Bos IW, Mulder SD, Verlinde SA, van Eijsden P, de Graan PN. Persistent reduction of hippocampal glutamine synthetase expression after status epilepticus in immature rats. Eur J Neurosci 2014;40:3711-9. [PMID: 25350774 DOI: 10.1111/ejn.12756] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
125 Pisani F, Pavlidis E, Facini C, La Morgia C, Fusco C, Cantalupo G. A 15-year epileptogenic period after perinatal brain injury. Funct Neurol 2017;32:49-53. [PMID: 28380324 DOI: 10.11138/fneur/2017.32.1.049] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
126 Löscher W, Klitgaard H, Twyman RE, Schmidt D. New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov 2013;12:757-76. [DOI: 10.1038/nrd4126] [Cited by in Crossref: 359] [Cited by in F6Publishing: 318] [Article Influence: 39.9] [Reference Citation Analysis]
127 Canas PM, Porciúncula LO, Simões AP, Augusto E, Silva HB, Machado NJ, Gonçalves N, Alfaro TM, Gonçalves FQ, Araújo IM, Real JI, Coelho JE, Andrade GM, Almeida RD, Chen JF, Köfalvi A, Agostinho P, Cunha RA. Neuronal Adenosine A2A Receptors Are Critical Mediators of Neurodegeneration Triggered by Convulsions. eNeuro 2018;5:ENEURO. [PMID: 30627646 DOI: 10.1523/ENEURO.0385-18.2018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
128 Langer M, Brandt C, Zellinger C, Löscher W. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats. Neuropharmacology 2011;61:1033-47. [PMID: 21736883 DOI: 10.1016/j.neuropharm.2011.06.015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
129 Tian M, Wang R, Hölscher C, Mi R, Yuan Z, Li D, Xue G. The novel GLP-1/GIP dual receptor agonist DA3-CH is neuroprotective in the pilocarpine-induced epileptogenesis rat model. Epilepsy Research 2019;154:97-106. [DOI: 10.1016/j.eplepsyres.2019.05.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
130 Carver CM, Hastings SD, Cook ME, Shapiro MS. Functional responses of the hippocampus to hyperexcitability depend on directed, neuron-specific KCNQ2 K+ channel plasticity. Hippocampus 2020;30:435-55. [PMID: 31621989 DOI: 10.1002/hipo.23163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
131 Berdichevsky Y, Dzhala V, Mail M, Staley KJ. Interictal spikes, seizures and ictal cell death are not necessary for post-traumatic epileptogenesis in vitro. Neurobiol Dis 2012;45:774-85. [PMID: 22115940 DOI: 10.1016/j.nbd.2011.11.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
132 Srivastava AK, White HS. Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats. Epilepsy Res 2013;104:26-34. [PMID: 23158096 DOI: 10.1016/j.eplepsyres.2012.10.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
133 Fang T, Valdes E, Frontera JA. Levetiracetam for Seizure Prophylaxis in Neurocritical Care: A Systematic Review and Meta-analysis. Neurocrit Care 2021. [PMID: 34286461 DOI: 10.1007/s12028-021-01296-z] [Reference Citation Analysis]
134 Deng C, Wu Z, Chen Y, Yu Z. Pinellia Total Alkaloids Modulate the GABAergic System in Hippocampal Formation on Pilocarpine-Induced Epileptic Rats. Chin J Integr Med 2020;26:138-45. [DOI: 10.1007/s11655-019-2944-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
135 Younus I, Reddy DS. Epigenetic interventions for epileptogenesis: A new frontier for curing epilepsy. Pharmacol Ther 2017;177:108-22. [PMID: 28279785 DOI: 10.1016/j.pharmthera.2017.03.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
136 Blades Golubovic S, Rossmeisl JH Jr. Status epilepticus in dogs and cats, part 1: etiopathogenesis, epidemiology, and diagnosis. J Vet Emerg Crit Care (San Antonio) 2017;27:278-87. [PMID: 28445615 DOI: 10.1111/vec.12605] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
137 Guo Y, Zhu LH, Zhao K, Guo XM, Yang MF. Statin use for the prevention of seizure and epilepsy in the patients at risk: A systematic review and meta-analysis of cohort studies. Epilepsy Res 2021;174:106652. [PMID: 33971584 DOI: 10.1016/j.eplepsyres.2021.106652] [Reference Citation Analysis]
138 Liu SJ, Zheng P, Wright DK, Dezsi G, Braine E, Nguyen T, Corcoran NM, Johnston LA, Hovens CM, Mayo JN, Hudson M, Shultz SR, Jones NC, O'Brien TJ. Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau. Brain 2016;139:1919-38. [PMID: 27289302 DOI: 10.1093/brain/aww116] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 9.8] [Reference Citation Analysis]
139 Licko T, Seeger N, Zellinger C, Russmann V, Matagne A, Potschka H. Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model. Epilepsia 2013;54:1176-85. [PMID: 23614482 DOI: 10.1111/epi.12196] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
140 Vega-García A, Neri-Gómez T, Buzoianu-Anguiano V, Guerra-Araiza C, Segura-Uribe J, Feria-Romero I, Orozco-Suarez S. Electroacupuncture Reduces Seizure Activity and Enhances GAD 67 and Glutamate Transporter Expression in Kainic Acid Induced Status Epilepticus in Infant Rats. Behav Sci (Basel) 2019;9:E68. [PMID: 31252624 DOI: 10.3390/bs9070068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 Imai T, Sugiyama T, Iwata S, Nakamura S, Shimazawa M, Hara H. Levetiracetam, an Antiepileptic Drug has Neuroprotective Effects on Intracranial Hemorrhage Injury. Neuroscience 2020;431:25-33. [DOI: 10.1016/j.neuroscience.2020.01.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
142 Ryley Parrish R, Albertson AJ, Buckingham SC, Hablitz JJ, Mascia KL, Davis Haselden W, Lubin FD. Status epilepticus triggers early and late alterations in brain-derived neurotrophic factor and NMDA glutamate receptor Grin2b DNA methylation levels in the hippocampus. Neuroscience 2013;248:602-19. [PMID: 23811393 DOI: 10.1016/j.neuroscience.2013.06.029] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 5.9] [Reference Citation Analysis]
143 Bankstahl M, Müller CJ, Wilk E, Schughart K, Löscher W. Generation and characterization of pilocarpine-sensitive C57BL/6 mice as a model of temporal lobe epilepsy. Behavioural Brain Research 2012;230:182-91. [DOI: 10.1016/j.bbr.2012.02.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
144 Engel J Jr, Pitkänen A. Biomarkers for epileptogenesis and its treatment. Neuropharmacology 2020;167:107735. [PMID: 31377200 DOI: 10.1016/j.neuropharm.2019.107735] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
145 Jafari M, Soerensen J, Bogdanović RM, Dimou L, Götz M, Potschka H. Long-term genetic fate mapping of adult generated neurons in a mouse temporal lobe epilepsy model. Neurobiology of Disease 2012;48:454-63. [DOI: 10.1016/j.nbd.2012.06.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
146 Batten SR, Matveeva EA, Whiteheart SW, Vanaman TC, Gerhardt GA, Slevin JT. Linking kindling to increased glutamate release in the dentate gyrus of the hippocampus through the STXBP5/tomosyn-1 gene. Brain Behav 2017;7:e00795. [PMID: 28948088 DOI: 10.1002/brb3.795] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
147 Gorter JA, van Vliet EA, Lopes da Silva FH. Which insights have we gained from the kindling and post-status epilepticus models? J Neurosci Methods 2016;260:96-108. [PMID: 25842270 DOI: 10.1016/j.jneumeth.2015.03.025] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
148 Mosińska P, Socała K, Nieoczym D, Laudon M, Storr M, Fichna J, Wlaź P. Anticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in mice. Behavioural Brain Research 2016;307:199-207. [DOI: 10.1016/j.bbr.2016.03.036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
149 Cela E, McFarlan AR, Chung AJ, Wang T, Chierzi S, Murai KK, Sjöström PJ. An Optogenetic Kindling Model of Neocortical Epilepsy. Sci Rep 2019;9:5236. [PMID: 30918286 DOI: 10.1038/s41598-019-41533-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
150 Steinmetz S, Tipold A, Löscher W. Epilepsy after head injury in dogs: a natural model of posttraumatic epilepsy. Epilepsia 2013;54:580-8. [PMID: 23294259 DOI: 10.1111/epi.12071] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
151 Klein P, Herr D, Pearl PL, Natale J, Levine Z, Nogay C, Sandoval F, Trzcinski S, Atabaki SM, Tsuchida T, van den Anker J, Soldin SJ, He J, McCarter R. Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy. Arch Neurol 2012;69:1290-5. [PMID: 22777131 DOI: 10.1001/archneurol.2012.445] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 5.2] [Reference Citation Analysis]
152 Barker-Haliski M, Harte-Hargrove LC, Ravizza T, Smolders I, Xiao B, Brandt C, Löscher W. A companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK3 Pharmacology Working Group of the ILAE/AES Joint Translational Task Force. Epilepsia Open 2018;3:53-68. [PMID: 30450485 DOI: 10.1002/epi4.12254] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
153 Löscher W, Hirsch LJ, Schmidt D. The enigma of the latent period in the development of symptomatic acquired epilepsy - Traditional view versus new concepts. Epilepsy Behav 2015;52:78-92. [PMID: 26409135 DOI: 10.1016/j.yebeh.2015.08.037] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
154 Liu J, Saponjian Y, Mahoney MM, Staley KJ, Berdichevsky Y. Epileptogenesis in organotypic hippocampal cultures has limited dependence on culture medium composition. PLoS One 2017;12:e0172677. [PMID: 28225808 DOI: 10.1371/journal.pone.0172677] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
155 Löscher W. Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs. Neurochem Res 2017;42:1873-88. [PMID: 28290134 DOI: 10.1007/s11064-017-2222-z] [Cited by in Crossref: 109] [Cited by in F6Publishing: 92] [Article Influence: 21.8] [Reference Citation Analysis]
156 Rettenbeck ML, von Rüden EL, Bienas S, Carlson R, Stein VM, Tipold A, Potschka H. Microglial ROS production in an electrical rat post-status epilepticus model of epileptogenesis. Neurosci Lett 2015;599:146-51. [PMID: 26007700 DOI: 10.1016/j.neulet.2015.05.041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
157 Zheng P, Shultz SR, Hovens CM, Velakoulis D, Jones NC, O’brien TJ. Hyperphosphorylated Tau is Implicated in Acquired Epilepsy and Neuropsychiatric Comorbidities. Mol Neurobiol 2014;49:1532-9. [DOI: 10.1007/s12035-013-8601-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
158 Singh T, Thapliyal S, Bhatia S, Singh V, Singh M, Singh H, Kumar A, Mishra A. Reconnoitering the transformative journey of minocycline from an antibiotic to an antiepileptic drug. Life Sci 2022;:120346. [PMID: 35065989 DOI: 10.1016/j.lfs.2022.120346] [Reference Citation Analysis]
159 Edafiogho IO, Qaddoumi MG, Ananthalakshmi KV, Phillips OA, Kombian SB. Synthesis, neuronal activity and mechanisms of action of halogenated enaminones. European Journal of Medicinal Chemistry 2014;76:20-30. [DOI: 10.1016/j.ejmech.2014.02.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
160 Varvel NH, Jiang J, Dingledine R. Candidate drug targets for prevention or modification of epilepsy. Annu Rev Pharmacol Toxicol 2015;55:229-47. [PMID: 25196047 DOI: 10.1146/annurev-pharmtox-010814-124607] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
161 Takahashi Y, Imai K, Ikeda H, Kubota Y, Yamazaki E, Susa F. Open study of pranlukast add-on therapy in intractable partial epilepsy. Brain and Development 2013;35:236-44. [DOI: 10.1016/j.braindev.2012.04.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
162 Bragin A, Li L, Almajano J, Alvarado-Rojas C, Reid AY, Staba RJ, Engel J Jr. Pathologic electrographic changes after experimental traumatic brain injury. Epilepsia 2016;57:735-45. [PMID: 27012461 DOI: 10.1111/epi.13359] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
163 Bascuñana P, Brackhan M, Leiter I, Keller H, Jahreis I, Ross TL, Bengel FM, Bankstahl M, Bankstahl JP. Divergent metabolic substrate utilization in brain during epileptogenesis precedes chronic hypometabolism. J Cereb Blood Flow Metab 2020;40:204-13. [PMID: 30375913 DOI: 10.1177/0271678X18809886] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
164 Meyer M, Kienzler-Norwood F, Bauer S, Rosenow F, Norwood BA. Removing entorhinal cortex input to the dentate gyrus does not impede low frequency oscillations, an EEG-biomarker of hippocampal epileptogenesis. Sci Rep 2016;6:25660. [PMID: 27160925 DOI: 10.1038/srep25660] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
165 Mazzuferi M, Kumar G, Rospo C, Kaminski RM. Rapid epileptogenesis in the mouse pilocarpine model: Video-EEG, pharmacokinetic and histopathological characterization. Experimental Neurology 2012;238:156-67. [DOI: 10.1016/j.expneurol.2012.08.022] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 8.2] [Reference Citation Analysis]
166 Schmidt D, Sillanpää M. Prevention of Epilepsy: Issues and Innovations. Curr Neurol Neurosci Rep 2016;16. [DOI: 10.1007/s11910-016-0695-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
167 Zhang Z, Sun T, Niu JG, He ZQ, Liu Y, Wang F. Amentoflavone protects hippocampal neurons: anti-inflammatory, antioxidative, and antiapoptotic effects. Neural Regen Res 2015;10:1125-33. [PMID: 26330838 DOI: 10.4103/1673-5374.160109] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
168 Williams-Karnesky RL, Sandau US, Lusardi TA, Lytle NK, Farrell JM, Pritchard EM, Kaplan DL, Boison D. Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis. J Clin Invest 2013;123:3552-63. [PMID: 23863710 DOI: 10.1172/JCI65636] [Cited by in Crossref: 146] [Cited by in F6Publishing: 95] [Article Influence: 16.2] [Reference Citation Analysis]
169 Zenki KC, Kalinine E, Zimmer ER, dos Santos TG, Mussulini BHM, Portela LVC, de Oliveira DL. Memantine decreases neuronal degeneration in young rats submitted to LiCl-pilocarpine-induced status epilepticus. NeuroToxicology 2018;66:45-52. [DOI: 10.1016/j.neuro.2018.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
170 Löscher W. Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models. Epilepsy Behav 2015;49:20-5. [PMID: 25819944 DOI: 10.1016/j.yebeh.2015.02.027] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
171 Kandeda AK, Taiwe GS, Moto FCO, Ngoupaye GT, Nkantchoua GCN, Njapdounke JSK, Omam JPO, Pale S, Kouemou N, Ngo Bum E. Antiepileptogenic and Neuroprotective Effects of Pergularia daemia on Pilocarpine Model of Epilepsy. Front Pharmacol 2017;8:440. [PMID: 28713279 DOI: 10.3389/fphar.2017.00440] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
172 Atabaki SM. Updates in the general approach to pediatric head trauma and concussion. Pediatr Clin North Am 2013;60:1107-22. [PMID: 24093898 DOI: 10.1016/j.pcl.2013.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
173 Jeong A, Wong M. Tuberous sclerosis complex as a model disease for developing new therapeutics for epilepsy. Expert Review of Neurotherapeutics 2016;16:437-47. [DOI: 10.1586/14737175.2016.1151788] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
174 Ogunjimi L, Yaria J, Makanjuola A, Alabi A, Osalusi B, Oboh D, Olusola-Bello M, Aderinola A, Ogunniyi A. Cognitive dysfunction in Nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy. Brain Behav 2021;11:e02038. [PMID: 33666367 DOI: 10.1002/brb3.2038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
175 Weaver DF. Design of innovative therapeutics for pharmacoresistant epilepsy: challenges and needs. Epilepsia 2013;54 Suppl 2:56-9. [PMID: 23646972 DOI: 10.1111/epi.12185] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
176 White HS, Löscher W. Searching for the ideal antiepileptogenic agent in experimental models: single treatment versus combinatorial treatment strategies. Neurotherapeutics 2014;11:373-84. [PMID: 24425186 DOI: 10.1007/s13311-013-0250-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 7.5] [Reference Citation Analysis]
177 Vezzani A, Fujinami RS, White HS, Preux PM, Blümcke I, Sander JW, Löscher W. Infections, inflammation and epilepsy. Acta Neuropathol 2016;131:211-34. [PMID: 26423537 DOI: 10.1007/s00401-015-1481-5] [Cited by in Crossref: 192] [Cited by in F6Publishing: 167] [Article Influence: 27.4] [Reference Citation Analysis]
178 Shimada T, Yamagata K. Pentylenetetrazole-Induced Kindling Mouse Model. J Vis Exp 2018. [PMID: 29985308 DOI: 10.3791/56573] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
179 Brandt C, Rankovic V, Töllner K, Klee R, Bröer S, Löscher W. Refinement of a model of acquired epilepsy for identification and validation of biomarkers of epileptogenesis in rats. Epilepsy Behav 2016;61:120-31. [PMID: 27343814 DOI: 10.1016/j.yebeh.2016.05.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
180 Bankstahl JP, Brandt C, Löscher W. Prolonged depth electrode implantation in the limbic system increases the severity of status epilepticus in rats. Epilepsy Research 2014;108:802-5. [DOI: 10.1016/j.eplepsyres.2014.01.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
181 Twele F, Bankstahl M, Klein S, Römermann K, Löscher W. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy. Neuropharmacology 2015;95:234-42. [PMID: 25839899 DOI: 10.1016/j.neuropharm.2015.03.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
182 Jiang G, Pu T, Li Z, Zhang X, Zhou R, Cao X, Yu J, Wang X. Lithium affects rat hippocampal electrophysiology and epileptic seizures in a dose dependent manner. Epilepsy Research 2018;146:112-20. [DOI: 10.1016/j.eplepsyres.2018.07.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
183 Welzel L, Twele F, Schidlitzki A, Töllner K, Klein P, Löscher W. Network pharmacology for antiepileptogenesis: Tolerability and neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status epilepticus mice. Epilepsy Res 2019;151:48-66. [PMID: 30831337 DOI: 10.1016/j.eplepsyres.2019.02.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
184 Klein S, Bankstahl M, Löscher W. Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice. Neuropharmacology 2015;90:53-62. [PMID: 25460186 DOI: 10.1016/j.neuropharm.2014.11.008] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 7.0] [Reference Citation Analysis]
185 Weaver DF, Pohlmann-eden B. Pharmacoresistant epilepsy: Unmet needs in solving the puzzle(s). Epilepsia 2013;54:80-5. [DOI: 10.1111/epi.12191] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
186 Romoli M, Mazzocchetti P, D'Alonzo R, Siliquini S, Rinaldi VE, Verrotti A, Calabresi P, Costa C. Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences. Curr Neuropharmacol. 2019;17:926-946. [PMID: 30592252 DOI: 10.2174/1570159x17666181227165722] [Cited by in Crossref: 46] [Cited by in F6Publishing: 23] [Article Influence: 23.0] [Reference Citation Analysis]
187 Li Q, Han Y, Du J, Jin H, Zhang J, Niu M, Qin J. Alterations of apoptosis and autophagy in developing brain of rats with epilepsy: Changes in LC3, P62, Beclin-1 and Bcl-2 levels. Neuroscience Research 2018;130:47-55. [DOI: 10.1016/j.neures.2017.08.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
188 Sime FB, Roberts JA, Jeffree RL, Pandey S, Adiraju S, Livermore A, Butler J, Parker SL, Wallis SC, Lipman J, Cotta MO. Population Pharmacokinetics of Levetiracetam in Patients with Traumatic Brain Injury and Subarachnoid Hemorrhage Exhibiting Augmented Renal Clearance. Clin Pharmacokinet 2021;60:655-64. [PMID: 33428169 DOI: 10.1007/s40262-020-00979-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 van Vliet EA, Forte G, Holtman L, den Burger JCG, Sinjewel A, de Vries HE, Aronica E, Gorter JA. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation: Mammalian Target of Rapamycin in Epilepsy. Epilepsia 2012;53:1254-63. [DOI: 10.1111/j.1528-1167.2012.03513.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 107] [Article Influence: 11.0] [Reference Citation Analysis]
190 Wilson SM, Khanna R. Specific binding of lacosamide to collapsin response mediator protein 2 (CRMP2) and direct impairment of its canonical function: implications for the therapeutic potential of lacosamide. Mol Neurobiol 2015;51:599-609. [PMID: 24944082 DOI: 10.1007/s12035-014-8775-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
191 Klein P, Dingledine R, Aronica E, Bernard C, Blümcke I, Boison D, Brodie MJ, Brooks-Kayal AR, Engel J Jr, Forcelli PA, Hirsch LJ, Kaminski RM, Klitgaard H, Kobow K, Lowenstein DH, Pearl PL, Pitkänen A, Puhakka N, Rogawski MA, Schmidt D, Sillanpää M, Sloviter RS, Steinhäuser C, Vezzani A, Walker MC, Löscher W. Commonalities in epileptogenic processes from different acute brain insults: Do they translate? Epilepsia 2018;59:37-66. [PMID: 29247482 DOI: 10.1111/epi.13965] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 21.0] [Reference Citation Analysis]
192 González MI. Regulation of the cell surface expression of chloride transporters during epileptogenesis. Neurosci Lett 2016;628:213-8. [PMID: 27345384 DOI: 10.1016/j.neulet.2016.06.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
193 Surguchov A, Surgucheva I, Sharma M, Sharma R, Singh V. Pore-Forming Proteins as Mediators of Novel Epigenetic Mechanism of Epilepsy. Front Neurol 2017;8:3. [PMID: 28149289 DOI: 10.3389/fneur.2017.00003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
194 Bartolini L, Libbey JE, Ravizza T, Fujinami RS, Jacobson S, Gaillard WD. Viral Triggers and Inflammatory Mechanisms in Pediatric Epilepsy. Mol Neurobiol 2019;56:1897-907. [PMID: 29978423 DOI: 10.1007/s12035-018-1215-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
195 Costa-Ferro ZS, de Borba Cunha F, de Freitas Souza BS, Leal MM, da Silva AA, de Bellis Kühn TI, Forte A, Sekiya EJ, Soares MB, Dos Santos RR. Antiepileptic and neuroprotective effects of human umbilical cord blood mononuclear cells in a pilocarpine-induced epilepsy model.Cytotechnology. 2014;66:193-199. [PMID: 23929461 DOI: 10.1007/s10616-013-9557-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
196 Schidlitzki A, Twele F, Klee R, Waltl I, Römermann K, Bröer S, Meller S, Gerhauser I, Rankovic V, Li D, Brandt C, Bankstahl M, Töllner K, Löscher W. A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsy. Sci Rep 2017;7:12191. [PMID: 28939854 DOI: 10.1038/s41598-017-12368-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
197 Mele M, Costa RO, Duarte CB. Alterations in GABAA-Receptor Trafficking and Synaptic Dysfunction in Brain Disorders. Front Cell Neurosci 2019;13:77. [PMID: 30899215 DOI: 10.3389/fncel.2019.00077] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
198 Chong SA, Balosso S, Vandenplas C, Szczesny G, Hanon E, Claes K, Van Damme X, Danis B, Van Eyll J, Wolff C, Vezzani A, Kaminski RM, Niespodziany I. Intrinsic Inflammation Is a Potential Anti-Epileptogenic Target in the Organotypic Hippocampal Slice Model. Neurotherapeutics 2018;15:470-88. [PMID: 29464573 DOI: 10.1007/s13311-018-0607-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
199 Liu J, Sternberg AR, Ghiasvand S, Berdichevsky Y. Epilepsy-on-a-Chip System for Antiepileptic Drug Discovery. IEEE Trans Biomed Eng 2019;66:1231-41. [PMID: 30235116 DOI: 10.1109/TBME.2018.2871415] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
200 Mukhtar I. Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: From pathogenesis to treatment target. Seizure 2020;82:65-79. [PMID: 33011590 DOI: 10.1016/j.seizure.2020.09.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
201 Baraban SC, Löscher W. What new modeling approaches will help us identify promising drug treatments? Adv Exp Med Biol 2014;813:283-94. [PMID: 25012385 DOI: 10.1007/978-94-017-8914-1_23] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
202 Chen LY, Liang J, Fei F, Ruan YP, Cheng HM, Wang Y, Chen Z, Xu CL. Pharmaco-genetic inhibition of pyramidal neurons retards hippocampal kindling-induced epileptogenesis. CNS Neurosci Ther 2020;26:1111-20. [PMID: 32596972 DOI: 10.1111/cns.13434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
203 Löscher W. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 2011;20:359-68. [PMID: 21292505 DOI: 10.1016/j.seizure.2011.01.003] [Cited by in Crossref: 505] [Cited by in F6Publishing: 455] [Article Influence: 45.9] [Reference Citation Analysis]
204 Zafar SF, Subramaniam T, Osman G, Herlopian A, Struck AF. Electrographic seizures and ictal-interictal continuum (IIC) patterns in critically ill patients. Epilepsy Behav 2020;106:107037. [PMID: 32222672 DOI: 10.1016/j.yebeh.2020.107037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
205 Römermann K, Bankstahl JP, Löscher W, Bankstahl M. Pilocarpine-induced convulsive activity is limited by multidrug transporters at the rodent blood-brain barrier. J Pharmacol Exp Ther 2015;353:351-9. [PMID: 25755207 DOI: 10.1124/jpet.114.221952] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
206 Amini E, Rezaei M, Mohamed Ibrahim N, Golpich M, Ghasemi R, Mohamed Z, Raymond AA, Dargahi L, Ahmadiani A. A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts. Mol Neurobiol 2015;52:492-513. [PMID: 25195699 DOI: 10.1007/s12035-014-8876-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
207 Deng X, Li G, Mei R, Sun S. Long term effects of tetramine poisoning: an observational study. Clin Toxicol (Phila) 2012;50:172-5. [PMID: 22315994 DOI: 10.3109/15563650.2012.657758] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
208 Henshall DC, Engel T. Contribution of apoptosis-associated signaling pathways to epileptogenesis: lessons from Bcl-2 family knockouts. Front Cell Neurosci 2013;7:110. [PMID: 23882182 DOI: 10.3389/fncel.2013.00110] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
209 Wolf BJ, Brackhan M, Bascuñana P, Leiter I, Langer BLN, Ross TL, Bankstahl JP, Bankstahl M. TSPO PET Identifies Different Anti-inflammatory Minocycline Treatment Response in Two Rodent Models of Epileptogenesis. Neurotherapeutics 2020;17:1228-38. [PMID: 31970667 DOI: 10.1007/s13311-020-00834-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
210 Menten-Dedoyart C, Serrano Navacerrada ME, Bartholome O, Sánchez Gil J, Neirinckx V, Wislet S, Becker G, Plenevaux A, Van den Ackerveken P, Rogister B. Development and Validation of a New Mouse Model to Investigate the Role of SV2A in Epilepsy. PLoS One 2016;11:e0166525. [PMID: 27861538 DOI: 10.1371/journal.pone.0166525] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
211 Barker-haliski ML, Friedman D, French JA, White HS. Disease Modification in Epilepsy: From Animal Models to Clinical Applications. Drugs 2015;75:749-67. [DOI: 10.1007/s40265-015-0395-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
212 Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011;134:2802-18. [DOI: 10.1093/brain/awr215] [Cited by in Crossref: 371] [Cited by in F6Publishing: 288] [Article Influence: 33.7] [Reference Citation Analysis]
213 Vega-García A, Santana-Gómez CE, Rocha L, Magdaleno-Madrigal VM, Morales-Otal A, Buzoianu-Anguiano V, Feria-Romero I, Orozco-Suárez S. Magnolia officinalis reduces the long-term effects of the status epilepticus induced by kainic acid in immature rats. Brain Res Bull 2019;149:156-67. [PMID: 30978383 DOI: 10.1016/j.brainresbull.2019.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
214 Reddy DS, Thompson W, Calderara G. Molecular mechanisms of sex differences in epilepsy and seizure susceptibility in chemical, genetic and acquired epileptogenesis. Neurosci Lett 2021;750:135753. [PMID: 33610673 DOI: 10.1016/j.neulet.2021.135753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
215 White HS, Barker-haliski M. Antiepileptic Drug Discovery. In: Shorvon S, Perucca E, Engel J, editors. The Treatment of Epilepsy. Oxford: John Wiley & Sons, Ltd; 2015. pp. 52-60. [DOI: 10.1002/9781118936979.ch4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
216 Rattka M, Brandt C, Bankstahl M, Bröer S, Löscher W. Enhanced susceptibility to the GABA antagonist pentylenetetrazole during the latent period following a pilocarpine-induced status epilepticus in rats. Neuropharmacology 2011;60:505-12. [DOI: 10.1016/j.neuropharm.2010.11.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
217 Yang Y, Zheng F, Xu X, Wang X. Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis. CNS Drugs 2016;30:677-88. [PMID: 27395404 DOI: 10.1007/s40263-016-0365-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
218 Pototskiy E, Dellinger JR, Bumgarner S, Patel J, Sherrerd-Smith W, Musto AE. Brain injuries can set up an epileptogenic neuronal network. Neurosci Biobehav Rev 2021:S0149-7634(21)00346-8. [PMID: 34384843 DOI: 10.1016/j.neubiorev.2021.08.003] [Reference Citation Analysis]
219 Cotta MO, Abdul-Aziz MH, Frey OR, Sime FB, Roberts JA, Roehr AC. What Are the Predictors for Achieving Therapeutic Levetiracetam Serum Concentrations in Adult Neurological Patients? Ther Drug Monit 2020;42:626-30. [PMID: 31977751 DOI: 10.1097/FTD.0000000000000731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
220 Simonato M, Löscher W, Cole AJ, Dudek FE, Engel J Jr, Kaminski RM, Loeb JA, Scharfman H, Staley KJ, Velíšek L, Klitgaard H. Finding a better drug for epilepsy: preclinical screening strategies and experimental trial design. Epilepsia 2012;53:1860-7. [PMID: 22708847 DOI: 10.1111/j.1528-1167.2012.03541.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
221 Piwowarczyk P, Rypulak E, Sysiak-Sławecka J, Nieoczym D, Socała K, Wlaź A, Wlaź P, Turski W, Czuczwar M, Borys M. Propofol and Sevoflurane Anesthesia in Early Childhood Do Not Influence Seizure Threshold in Adult Rats. Int J Environ Res Public Health 2021;18:12367. [PMID: 34886095 DOI: 10.3390/ijerph182312367] [Reference Citation Analysis]
222 Jeong KH, Kim JY, Choi YS, Lee MY, Kim SY. Influence of aspirin on pilocarpine-induced epilepsy in mice. Korean J Physiol Pharmacol 2013;17:15-21. [PMID: 23439794 DOI: 10.4196/kjpp.2013.17.1.15] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
223 Minge D, Bähring R. Acute alterations of somatodendritic action potential dynamics in hippocampal CA1 pyramidal cells after kainate-induced status epilepticus in mice. PLoS One 2011;6:e26664. [PMID: 22039527 DOI: 10.1371/journal.pone.0026664] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
224 Słowiński P, Sheybani L, Michel CM, Richardson MP, Quairiaux C, Terry JR, Goodfellow M. Background EEG Connectivity Captures the Time-Course of Epileptogenesis in a Mouse Model of Epilepsy. eNeuro 2019;6:ENEURO. [PMID: 31346002 DOI: 10.1523/ENEURO.0059-19.2019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
225 Miratashi Yazdi SA, Abbasi M, Miratashi Yazdi SM. Epilepsy and vitamin D: a comprehensive review of current knowledge. Rev Neurosci 2017;28:185-201. [PMID: 27988507 DOI: 10.1515/revneuro-2016-0044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
226 Kulbida R, Wang Y, Mandelkow EM, Schoch S, Becker AJ, van Loo KM. Molecular imaging reveals epileptogenic Ca2+-channel promoter activation in hippocampi of living mice. Brain Struct Funct 2015;220:3067-73. [PMID: 24889163 DOI: 10.1007/s00429-014-0801-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
227 Klein P, Tyrlikova I. Prevention of epilepsy: Should we be avoiding clinical trials? Epilepsy Behav 2017;72:188-94. [PMID: 28647441 DOI: 10.1016/j.yebeh.2017.05.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
228 Kobylarek D, Iwanowski P, Lewandowska Z, Limphaibool N, Szafranek S, Labrzycka A, Kozubski W. Advances in the Potential Biomarkers of Epilepsy. Front Neurol 2019;10:685. [PMID: 31312171 DOI: 10.3389/fneur.2019.00685] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 13.3] [Reference Citation Analysis]
229 White HS, Alex AB, Pollock A, Hen N, Shekh-Ahmad T, Wilcox KS, McDonough JH, Stables JP, Kaufmann D, Yagen B, Bialer M. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage. Epilepsia 2012;53:134-46. [PMID: 22150444 DOI: 10.1111/j.1528-1167.2011.03338.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
230 Turnbull D, Singatullina N, Reilly C. A Systematic Appraisal of Neurosurgical Seizure Prophylaxis: Guidance for Critical Care Management. J Neurosurg Anesthesiol 2016;28:233-49. [PMID: 26192247 DOI: 10.1097/ANA.0000000000000206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
231 Zhang Y, Gao B, Zheng F, Lu S, Li Y, Xiong Y, Yang Q, Yang Y, Fu P, Xiao F, Wang X. The Phosphodiesterase 10A Inhibitor PF-2545920 Enhances Hippocampal Excitability and Seizure Activity Involving the Upregulation of GluA1 and NR2A in Post-synaptic Densities. Front Mol Neurosci 2017;10:100. [PMID: 28439226 DOI: 10.3389/fnmol.2017.00100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
232 Schidlitzki A, Bascuñana P, Srivastava PK, Welzel L, Twele F, Töllner K, Käufer C, Gericke B, Feleke R, Meier M, Polyak A, Ross TL, Gerhauser I, Bankstahl JP, Johnson MR, Bankstahl M, Löscher W. Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy. Neurobiol Dis 2020;134:104664. [PMID: 31678583 DOI: 10.1016/j.nbd.2019.104664] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
233 Singh T, Mishra A, Goel RK. PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability. Metab Brain Dis 2021;36:1573-90. [PMID: 34427842 DOI: 10.1007/s11011-021-00823-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
234 Geronzi U, Lotti F, Grosso S. Oxidative stress in epilepsy. Expert Review of Neurotherapeutics 2018;18:427-34. [DOI: 10.1080/14737175.2018.1465410] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
235 Kinboshi M, Ikeda A, Ohno Y. Role of Astrocytic Inwardly Rectifying Potassium (Kir) 4.1 Channels in Epileptogenesis. Front Neurol 2020;11:626658. [PMID: 33424762 DOI: 10.3389/fneur.2020.626658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
236 Bhowmik M, Khanam R, Vohora D. Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives. Br J Pharmacol 2012;167:1398-414. [PMID: 22758607 DOI: 10.1111/j.1476-5381.2012.02093.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 8.1] [Reference Citation Analysis]
237 Chen F, He X, Luan G, Li T. Role of DNA Methylation and Adenosine in Ketogenic Diet for Pharmacoresistant Epilepsy: Focus on Epileptogenesis and Associated Comorbidities. Front Neurol 2019;10:119. [PMID: 30863356 DOI: 10.3389/fneur.2019.00119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
238 Doeser A, Dickhof G, Reitze M, Uebachs M, Schaub C, Pires NM, Bonifácio MJ, Soares-da-silva P, Beck H. Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug. Brain 2015;138:371-87. [DOI: 10.1093/brain/awu339] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
239 Kheiri F, Bragin A, Engel J Jr, Almajano J, Winden E. Non-linear classification of heart rate parameters as a biomarker for epileptogenesis. Epilepsy Res 2012;100:59-66. [PMID: 22305585 DOI: 10.1016/j.eplepsyres.2012.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
240 Curia G, Lucchi C, Vinet J, Gualtieri F, Marinelli C, Torsello A, Costantino L, Biagini G. Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic? Curr Med Chem 2014;21:663-88. [PMID: 24251566 DOI: 10.2174/0929867320666131119152201] [Cited by in Crossref: 134] [Cited by in F6Publishing: 125] [Article Influence: 16.8] [Reference Citation Analysis]
241 Klee R, Töllner K, Rankovic V, Römermann K, Schidlitzki A, Bankstahl M, Löscher W. Network pharmacology for antiepileptogenesis: Tolerability of multitargeted drug combinations in nonepileptic vs. post-status epilepticus mice. Epilepsy Res 2015;118:34-48. [PMID: 26600369 DOI: 10.1016/j.eplepsyres.2015.11.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
242 Bartolini L, Theodore WH, Jacobson S, Gaillard WD. Infection with HHV-6 and its role in epilepsy. Epilepsy Research 2019;153:34-9. [DOI: 10.1016/j.eplepsyres.2019.03.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
243 Oliveira CVD, Grigoletto J, Canzian JM, Duarte MMMF, Duarte T, Furian AF, Oliveira MS. Effect of atorvastatin on behavioral alterations and neuroinflammation during epileptogenesis. Epilepsy & Behavior 2018;78:109-17. [DOI: 10.1016/j.yebeh.2017.10.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
244 Lopes MW, Lopes SC, Santos DB, Costa AP, Gonçalves FM, de Mello N, Prediger RD, Farina M, Walz R, Leal RB. Time course evaluation of behavioral impairments in the pilocarpine model of epilepsy. Epilepsy Behav 2016;55:92-100. [PMID: 26773677 DOI: 10.1016/j.yebeh.2015.12.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
245 Prince DA. How do we make models that are useful in understanding partial epilepsies? Adv Exp Med Biol 2014;813:233-41. [PMID: 25012380 DOI: 10.1007/978-94-017-8914-1_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
246 Boison D. The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine. Front Mol Neurosci 2016;9:26. [PMID: 27147960 DOI: 10.3389/fnmol.2016.00026] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
247 Upaganlawar AB, Wankhede NL, Kale MB, Umare MD, Sehgal A, Singh S, Bhatia S, Al-Harrasi A, Najda A, Nurzyńska-Wierdak R, Bungau S, Behl T. Interweaving epilepsy and neurodegeneration: Vitamin E as a treatment approach. Biomed Pharmacother 2021;143:112146. [PMID: 34507113 DOI: 10.1016/j.biopha.2021.112146] [Reference Citation Analysis]
248 Wu T, Ido K, Osada Y, Kotani S, Tamaoka A, Hanada T. The neuroprotective effect of perampanel in lithium-pilocarpine rat seizure model. Epilepsy Res 2017;137:152-8. [PMID: 28624183 DOI: 10.1016/j.eplepsyres.2017.06.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
249 Bröer S, Löscher W. Novel combinations of phenotypic biomarkers predict development of epilepsy in the lithium–pilocarpine model of temporal lobe epilepsy in rats. Epilepsy & Behavior 2015;53:98-107. [DOI: 10.1016/j.yebeh.2015.09.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
250 Bröer S, Käufer C, Haist V, Li L, Gerhauser I, Anjum M, Bankstahl M, Baumgärtner W, Löscher W. Brain inflammation, neurodegeneration and seizure development following picornavirus infection markedly differ among virus and mouse strains and substrains. Exp Neurol 2016;279:57-74. [PMID: 26892877 DOI: 10.1016/j.expneurol.2016.02.011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
251 Löscher W. Strategies for antiepileptogenesis: Antiepileptic drugs versus target-specific approaches. Epilepsia 2010;51:88-88. [DOI: 10.1111/j.1528-1167.2010.02874.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
252 Eslami M, Sayyah M, Soleimani M, Alizadeh L, Hadjighassem M. Lipopolysaccharide preconditioning prevents acceleration of kindling epileptogenesis induced by traumatic brain injury. J Neuroimmunol 2015;289:143-51. [PMID: 26616884 DOI: 10.1016/j.jneuroim.2015.11.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
253 Łukawski K, Andres-Mach M, Czuczwar M, Łuszczki JJ, Kruszyński K, Czuczwar SJ. Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies. Pharmacol Rep 2018;70:284-93. [PMID: 29477036 DOI: 10.1016/j.pharep.2017.07.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
254 Bogdanović RM, Syvänen S, Michler C, Russmann V, Eriksson J, Windhorst AD, Lammertsma AA, de Lange EC, Voskuyl RA, Potschka H. (R)-[11C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: evaluation in a rat epilepsy model. Neuropharmacology 2014;85:104-12. [PMID: 24880085 DOI: 10.1016/j.neuropharm.2014.05.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
255 Saha L, Chakrabarti A. Understanding the anti-kindling role and its mechanism of Resveratrol in Pentylenetetrazole induced-kindling in a rat model. Pharmacology Biochemistry and Behavior 2014;120:57-64. [DOI: 10.1016/j.pbb.2014.01.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
256 Kaminski RM, Rogawski MA, Klitgaard H. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments. Neurotherapeutics 2014;11:385-400. [PMID: 24671870 DOI: 10.1007/s13311-014-0266-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 7.8] [Reference Citation Analysis]
257 Langer M, Brandt C, Löscher W. Marked strain and substrain differences in induction of status epilepticus and subsequent development of neurodegeneration, epilepsy, and behavioral alterations in rats. Epilepsy Research 2011;96:207-24. [DOI: 10.1016/j.eplepsyres.2011.06.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
258 Zheng P, Shultz S, Hovens C, O’brien TJ. Animal Models of Acquired Epilepsy and Tauopathies. Models of Seizures and Epilepsy. Elsevier; 2017. pp. 1031-41. [DOI: 10.1016/b978-0-12-804066-9.00072-9] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
259 Yang CS, Chiu SC, Liu PY, Wu SN, Lai MC, Huang CW. Gastrodin alleviates seizure severity and neuronal excitotoxicities in the rat lithium-pilocarpine model of temporal lobe epilepsy via enhancing GABAergic transmission. J Ethnopharmacol 2021;269:113751. [PMID: 33359863 DOI: 10.1016/j.jep.2020.113751] [Reference Citation Analysis]